Michael ZürcherOct 14, 20252 min readINSIGHTSOrphan Drug Designation: Key differences between Switzerland and the EU
Michael ZürcherMay 1, 20252 min readTEAM & PARTNERSAnnabelle Müller joins Swizzard as Market Access Director
Michael ZürcherMar 19, 20251 min readINSIGHTSSuccess factors for foreign players entering the Swiss pharmaceuticals market
Michael ZürcherFeb 6, 20251 min readCOMPANY NEWSA year of growth in 2024: Swizzard’s 27th client, two new services and comprehensive support for the Swiss Market
